A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition
Lars M. Schiffmann(University Hospital Cologne), Oliver Coutelle(University of Cologne)
Cited by 37
Related Papers
Tumor Microenvironment of Esophageal Cancer
|Cancers|2021|41